Influence of Donor Factors on Early Function of Graft Kidneys

Size: px
Start display at page:

Download "Influence of Donor Factors on Early Function of Graft Kidneys"

Transcription

1 Influence of Donor Factors on Early Function of Graft Kidneys J Am Soc Nephrol 10: , 1999 DEEPIKA SURI and TIMOTHY W. MEYER Departments of Medicine, Palo Alto Veterans Administration Health Care Service and Stanford University, Palo Alto, California. Abstract. Factors which influence graft function can be divided into donor factors that affect both kidneys from the same donor equally and postdonor factors that affect each kidney individually. This study assessed the influence of donor factors on graft function early after transplantation. Sixty-one donors who provided kidneys that were transplanted locally into two separate recipients were identified. Recipient creatinine clearance values were estimated from serum creatinine concentrations using a computer model. Pairwise ANOVA showed that donor factors accounted for 35 to 45% of the variation in recipient creatinine clearance from d to wk posttransplantation. Although donor factors had a large aggregate effect during this period, individual factors that influenced graft function could not be identified from analysis of donor medical records. At 6 mo after transplantation, the effect of donor factors on graft function was no longer discernible. These results show that the condition of the donor exerts an important influence on graft function early after transplantation. More detailed study is required to identify individual factors that contribute to this effect. Function of cadaver kidneys over the first few days after transplantation ranges from near zero to normal (1 4). Most of the kidneys that exhibit poor initial function eventually recover adequate function. Delayed function, however, has significant adverse consequences. It prolongs hospitalization and complicates immunosuppressive therapy. In addition, when defined by a requirement for dialysis during the first week after transplantation, delayed function is associated with an increased incidence of acute rejection and increased rate of graft loss over the first year (5,6). Some, although not all, studies have found that delayed function is also associated with an increased rate of late graft loss (5 9). Delayed graft function is generally attributed to reperfusion injury following renal ischemia (1 4). The factors that cause some grafts to exhibit delayed function while others function promptly, however, are poorly understood. Theoretically, these factors can be divided into two groups. The first group is composed of donor factors, which should affect both kidneys from the same donor equally. These could include features of the donor s medical condition before the injury which caused brain death, the nature of this injury, and events during the terminal hospitalization and procurement surgery. The second group is composed of post-donor factors, which are not expected to affect both kidneys from the same donor equally. These could include consequences of cold ischemia, features of the recipient s medical condition, and events during transplant Received September 14, Accepted December 15, Correspondence to Dr. Timothy Meyer, Departments of Medicine, Palo Alto VAHCS and Stanford University, Palo Alto VAHCS, 3801 Miranda Avenue, Palo Alto, CA Phone: , ext ; Fax: ; meyer.timothy_w@palo-alto.va.gov / Journal of the American Society of Nephrology Copyright 1999 by the American Society of Nephrology surgery and subsequent hospitalization. The current study compared the influence of donor and postdonor factors by analyzing the extent to which kidneys from the same donor exhibit similar function posttransplantation. Materials and Methods Records of the California Transplant Donor Network (CTDN) for 1996 were reviewed to identify donors who provided kidneys transplanted locally into two separate recipients. Of a total of 185 kidney donors during the year, 57 were excluded because one or both kidneys were transplanted outside the network, 37 were excluded because another organ was transplanted along with the kidney in at least one recipient, 14 were excluded because both kidneys were transplanted into the same recipient, 13 were excluded because one kidney was discarded, and an additional three were excluded because they were under 10 yr of age. The remaining 61 donors and the 1 recipients of their kidneys were included in this study. Donor clinical data were obtained from a computerized database maintained by CTDN. Donor creatinine clearance values were estimated using the formula of Cockcroft and Gault (10) for adults and the formula of Schwartz et al. (11) for adolescents. Recipient data were obtained from medical records maintained by the local transplant centers and referring nephrologists. Creatinine clearance during the period from 4 to 7 h after transplantation was estimated using a modification of the method described by Moran and Myers (1). The age, gender, and weight of the recipient, the time of implantation, and all recorded serum creatinine values and the times at which they were measured were entered into a computer program. The program then estimated serum creatinine values at 4, 48, and 7 h by interpolation and calculated the average serum creatinine concentration over 4 to 48 and 48 to 7 h. Body creatinine content was calculated as the product of serum creatinine concentration and body water content. Values for creatinine clearance during 4 to 48 h and 48 to 7 h posttransplantation were then obtained from the appropriate values for serum creatinine concentration, body creatinine content, and creatinine production as estimated by the formulas of Cockcroft and Gault and Schwartz et al. In recipients who were hemodialyzed, clearance

2 1318 Journal of the American Society of Nephrology J Am Soc Nephrol 10: , 1999 values were calculated after excluding the period between the last serum creatinine measurement before dialysis and the first creatinine measurement after dialysis. Records of dialysis time and/or serum creatinine levels were insufficient to allow this correction for the period from 4 to 48 h in three patients and for the period 48 to 7 h in nine patients. In these patients, clearance values were calculated without correcting for dialysis. When the uncorrected values were less than 10 ml/min, they were used in the analysis. In other patients, the clearance was set at 10 ml/min. In the two recipients who underwent peritoneal dialysis, the computer-generated creatinine clearance values were less than 1 ml/min, and no attempt to correct them for dialytic clearance was made. Creatinine clearance values at wk and 6 mo were estimated using the formulas of Cockcroft and Gault and Schwartz et al. The clearance at wk was calculated using the average of all serum creatinine values from day 13 to day 15 in 100 patients. When no creatinine values were available from this interval, values were averaged from day 1 to 16 (18 patients) or from day 9 to 19 (4 patients). The clearance at 6 mo was calculated using the average of all serum creatinine values from 4 to 7 mo excluding values obtained during episodes of acute rejection. One recipient who died and one recipient who was lost to follow-up were excluded from analysis so the number of pairs analyzed at 6 mo was 59. Graft creatinine clearance was recorded as zero in two patients who underwent transplant nephrectomy and had returned to dialysis at 6 mo. Episodes of acute rejection during the first 6 mo, established by biopsy or by use of pulse immunosuppressive therapy to reverse increases in serum creatinine, were identified by review of clinic records. Statistical Analyses The relation of function in kidneys from the same donor was assessed using a modification of the method described by Cosio et al. (13). Recipients of kidneys from the same donor were first randomly designated the A recipient and the B recipient. An ANOVA was then used to estimate the contribution of donor factors to the total variation observed in graft function. For this analysis, the difference between graft function in an individual recipient and the mean graft function of the study group was assumed to be the sum of two normally distributed variables. The first of these variables, F i, represented the portion of the difference ascribable to donor factors and thus had the same value for both kidneys from the ith donor. The second, E ij with j A or B, represented the portion of the difference ascribable to postdonor factors and thus had a different value for each kidney. The posttransplant clearance values x ia and x ib for the two kidneys of the ith donor were thus expressed as: and x ia F i E ia (1) x ib F i E ib. () The values of F i and E ij in individual patients could not be determined, but the average magnitude of F i and E ij could be obtained from the related variables f i and e i, where: and f i x ia x ib (3) e i x ia x ib. (4) It will be seen that f i reflected the degree to which the average function of a pair of kidneys differed from the grand mean and that e i reflected the degree to which function in two kidneys from the same donor differed from each other. Standard ANOVA calculations provided values for f i, e i, and the sum of squares, where: Sum of squares f i e i. (5) Since the values for E ij and F i were presumed to be normally distributed and the number of pairs was large, values for E ij and F i obeyed the relationships: and Sum of squares F i E i (6) E i e i. (7) The latter relationship reflects the tendency of the real influence of recipient factors E ij to have a greater magnitude than calculated values for e i. Relationships 6 and 7 were combined to obtain: F i Sum of squares e i. (8) The fraction of the overall variability of graft function that was attributable to donor factors was then estimated as: F i Sum of squares Sum of squares e i. (9) Sum of squares The test was used to determine whether there was a tendency for both recipients of kidneys from the same donor to be dialyzed during the first 4 d posttransplantation. The contribution of individual donor factors to graft function posttransplantation was assessed by linear regression for parametric variables and by unpaired t test for nonparametric variables. All statistical calculations were done with a standard software program (StatView 4.5, Abacus Concepts, Berkeley, CA). Values are presented as the mean 1 SD throughout. Results Clinical data for the donors are summarized in Table 1. The mean age was yr, and there were 1 women and 40 men. The serum creatinine value immediately before procurement was mg/dl. The maximum serum creatinine recorded during hospitalization was slightly higher, averaging mg/dl, but did not exceed. mg/dl in any patient. Body weight was 80 kg and the estimated creatinine clearance before procurement was ml/min. The Table 1. Clinical characteristics of the 61 donors a Age (yr) to 66 Gender (F/M) 4/80 Maximum serum creatinine to. (mg/dl) Final serum creatinine (mg/dl) to 1.9 Body weight (kg) 80 6 to 136 Estimated creatinine clearance to 171 (ml/min) Duration of hospitalization (h) to 13 a Values are the mean 1 SD and the range observed.

3 J Am Soc Nephrol 10: , 1999 Donor Effect on Early Graft Kidney Function 1319 duration of the terminal hospitalization was h. Brain death was attributed to trauma in 4 patients, to cerebrovascular accident in 9 patients, and to other causes in eight patients. Kidneys from the 61 donors were transplanted into 53 women and 69 men with an average age of yr. Graft function in the recipients is summarized in Table. Serum creatinine was mg/dl over the period from 4 to 48 h postimplantation and mg/dl over the period from 48 to 7 h postimplantation. The large SD in these values reflected a wide range of early graft function. Creatinine clearance values estimated from body size and the rate of change in serum creatinine varied from near zero to near normal. Thirtyfour of the 1 recipients were dialyzed over the first 4 d postimplantation. The average serum creatinine declined to.8.5 mg/dl at wk and mg/dl at 6 mo. Regression plots revealed that early function in kidneys obtained from the same donor tended to be similar, as depicted in Figure 1. By 6 mo after transplantation, this tendency was no longer apparent, as depicted in Figure. Estimates of the relative influence of donor and postdonor factors on graft function are summarized in Table 3. Values for F i were between 35 and 45% of the total sum of squares at 4 to 8 h, 48 to 7 h, and wk after transplantation. These results indicate that donor factors accounted for slightly less that half of the variability in graft kidney function during the early posttransplant period. In contrast, the value for F i was only 10% of the total sum of squares at 6 mo, indicating that the residual effect of donor factors accounted for very little of the variability in graft function observed at this interval. As illustrated in Figure 3, the influence of donor factors on early function could not be detected when dialysis was used as the only index of poor function. Both recipients of kidneys from the same donor were dialyzed during the first 4 d in only four patients. This number was not greater than that which would have resulted from chance alone given a 8% overall frequency of dialysis during this interval ( 0., P 0.6). Good graft function during the early posttransplant period was associated with a reduced incidence of acute rejection over the first 6 mo. The median estimated clearance at 4 to 8 h was ml/min. Acute rejection was observed in 19% of patients with clearance values greater than the median and in 38% of patients with clearance values less than or equal to the median ( 5.1, P 0.05). Very good early graft function was associated with Table. Graft function in the 1 recipients a Period Serum Creatinine (mg/dl) Creatinine Clearance (ml/min) 4 to 48 h to 7 h wk mo a Serum creatinine values for four recipients and creatinine clearance values for two recipients are not included in data at 6 mo. Figure 1. Early function of graft kidneys from the same donor. Creatinine clearance values for kidneys from the same donor tended to be similar during the first wk after transplantation. Linear regression yielded values of r 0.13, P at 4 to 48 h, r 0.16, P 0.00 at 48 to 7 h, and r 0.1, P at wk.

4 130 Journal of the American Society of Nephrology J Am Soc Nephrol 10: , 1999 observed between the postdonor factor cold ischemia time and early graft function (r 0.07, P 0.00). Figure. Function at 6 mo of graft kidneys from the same donor. The tendency for kidneys from the same donor to exhibit similar creatinine clearance values is no longer apparent. a still lower incidence of acute rejection. Acute rejection was observed in only 7% of patients whose estimated clearance values at 4 to 48 h fell in the upper quartile ( 4 ml/min, 8.8, P 0.01). The relation of graft function to individual donor factors is summarized in Table 4. The table presents creatinine clearance values at 4 to 48 h, but similar results were obtained when creatinine clearance values at 48 to 7 h and 14 d were analyzed. Grafts from donors without a history of hypertension appeared to function better than grafts from donors with such a history. This relation could not be assigned statistical significance by conventional criteria, however, because correcting for analysis of multiple variables would raise the P value above Other features of the donor medical history, including death at a young age and death due to trauma, did not exert a detectable influence on graft function. Graft function also was not correlated with recorded features of the donor condition in hospital. The authors had hypothesized that graft function would be correlated with donor kidney function before procurement, but this did not prove to be the case. Low systolic BP and the use of dopamine, which were considered potential indices of impaired donor hemodynamic function, did not predict poor function. Use of dopamine at a rate 10 g/kg per min (30 patients) or of pressors other than dopamine (3 patients) likewise did not predict poor function. Examination of donor laboratory values including hematocrit, platelet count, prothrombin time, liver function tests, and the anion gap also failed to identify factors that influenced graft function. In contrast, a significant inverse correlation was Discussion The chief aim of the current study was to assess the relative influence of donor and postdonor factors on graft function early after transplantation. Graft function was evaluated by modeling creatinine clearance rates rather than simply by analyzing serum creatinine values or the use of dialysis. Results indicated that early graft function varied continuously over a wide range. Statistical analysis was performed using the ANOVA as described by Cosio et al. (13) with a modification to prevent overestimation of the importance of donor factors. Application of these methods suggested that donor factors accounted for 35 to 45% of the variability in graft function over the period between 4 h and wk after transplantation. The donor effect on graft function could no longer be detected at 6 mo. Presumably, recovery from reperfusion injury reduced the magnitude of the donor effect. In addition, the influence of events between wk and 6 mo would reduce the relative importance of donor factors and make their effect hard to detect in a study of the present size. Good early graft function was associated with a reduced incidence of acute rejection, in accord with the findings of previous studies (6,7,14). Relatively few studies have previously compared graft function in recipients of kidneys from the same donor. Pfaff et al. (15) identified recipient pairs who received kidneys from 77 donors at a single center. As in the current study, analysis did not reveal an influence of donor factors on the requirement for dialysis during the early posttransplant period. It is not surprising that the effect of donor factors is obscured when dialysis is used as the sole index of poor graft function. The decision to use dialysis is influenced by features of the recipient s condition other than graft function, including extracellular fluid volume, electrolyte status, and the extent to which uremia was corrected by dialysis before transplantation. Moreover, the use of dialysis as an index of function requires that graft function be divided into two categories rather than considered as a continuous variable. This process in itself tends to obscure the effect of donor factors. Cosio et al. (13) addressed this problem by comparing serum creatinine values in recipients of kidneys from the same donor. They found a statistically significant correlation between serum creatinine values in 184 recipient pairs evaluated at 10 d and in 139 recipient pairs evaluated at 6 mo. Graft function at earlier intervals was not assessed. Our findings at 14 d appear similar to those obtained by Cosio et al. (13) at 10 d. Our findings at 6 mo, however, are different. We could not detect an effect of donor factors at this interval. Cosio et al. (13) concluded that most of the variation in serum creatinine at 6 mo was attributable to donor factors, although the correlation between creatinine values in recipient pairs was weak. The discrepancy between this result and that of the current study is due in part to a difference in statistical methods. As described in Materials and Methods, we corrected for the tendency of the variability within donor pairs to under-

5 J Am Soc Nephrol 10: , 1999 Donor Effect on Early Graft Kidney Function 131 Table 3. Aggregate influence of donor factors a Parameter 4 to 48 h 48 to 7 h wk 6 mo Sum of squares 48,714 66,95 91,983 89,47 E i 8,860 37,01 58,338 80,450 F i 19,854 9,940 33,645 8,797 % donor factors a Values for percentage of donor factors were calculated by dividing values for F i by the sum of squares. Figure 3. Dialysis during the first 4 d inrecipients of kidneys from the same donor. The influence of donor factors could not be detected when dialysis was used as the only index of poor function. estimate the influence of postdonor factors. This correction reduces the portion of the variability ascribed to donor factors. It should be emphasized that errors in the assessment of graft function will cause underestimation of the importance of donor factors. This is because such errors tend to exaggerate the difference in function of kidneys from the same donor. Estimation of creatinine clearance should provide a more accurate measure of graft function than serum creatinine alone. As used in the current study, however, this method requires calculation of creatinine production on the basis of age, gender, body weight, and height. Variations in muscle mass among people of the same age, gender, weight, and height, which may be greater among dialysis patients than healthy subjects, are ignored. Creatinine clearance, moreover, provides an imperfect measure of GFR when renal function is reduced (16,17). Our calculation that donor factors accounted for 35 to 45% of the variation in graft creatinine clearance from 4 h to wk posttransplantation may therefore have underestimated the influence of donor factors on graft function. The current study revealed a large aggregate effect of donor factors but failed to identify individual donor factors that affected graft function. Previous studies have likewise left most of the variation in early graft function unaccounted for. The largest of these studies have described data from the U.S. Renal Data System (18), the UNOS Scientific Renal Transplant Registry (6), the European Multicenter Study Group (19,0), and two individual centers (13,15). In most cases, delayed graft function has been defined by the requirement for dialysis during the first week posttransplantation. The only donor factor associated with an increased risk of delayed graft function in the majority of the studies has been older age. The strength of the age-associated risk has been moderate, which may explain why the inverse correlation between donor age and early graft function did not attain statistical significance in our smaller study. Two of the larger studies identified death due to cerebrovascular accident as an age-independent risk factor for delayed graft function and one identified donor obesity as a risk factor (15,19). Presumably, vascular disease associated with these factors could make the kidney more susceptible to ischemic injury. A remarkable feature of previous studies has been the absence of a strong association between donor hemodynamic state and the risk of delayed graft function. Hypotension and pressor use were associated with an increased risk of delayed graft function in two smaller studies (1,), but this result was not confirmed by the larger studies of Pfaff et al. (15) and Ploeg et al. (19). We also observed no correlation between graft function and recorded hemodynamic parameters or pressor use. Given the aggregate effect of donor factors, the failure to identify important individual factors could be attributed to two causes. First, many individual donor factors could combine to account for a large portion of the variability in graft function without any single factor having a large enough influence to be identified in a study of the present size. If this is the case, identification of donor factors that influence graft function will remain difficult. A second possibility is that important donor factors are not described in routine medical records. Some factors, such as the severity and duration of hypotension and associated evidence of impaired tissue perfusion, may be noted but not described in adequate detail. Other factors, including the structure of the donor kidney and the adequacy of its perfusion during procurement surgery, are not routinely evaluated. More detailed studies will be required to assess the extent to which such factors influence graft function.

6 13 Journal of the American Society of Nephrology J Am Soc Nephrol 10: , 1999 Table 4. Relation of graft function to individual factors a Type of Variable Recorded Value Creatinine Clearance at 4 to 48 h P Value Nonparametric donor variables Yes No history of hypertension history of smoking death due to trauma dopamine used Parametric donor variables Lower Tertile Mid Tertile Upper Tertile age (yr) creatinine clearance (ml/min) minimum SBP (mmhg) cold ischemia time (h) a Creatinine clearance values are given for recipients whose donors were in the yes and no categories for the nonparametric variables and in the lower, mid, and upper tertiles for the parametric variables. The P values given were obtained using the unpaired t test for nonparametric variables and linear regression for parametric variables and were not corrected for analysis of multiple variables. The cause of death was not determined in one patient. Histories of hypertension, smoking, and dopamine use were not obtained in two patients each. Acknowledgments This work was supported by the Research Service of the Veterans Administration and the Baxter Extramural Grant Program. Dr. Suri was supported by a Dean s Fellowship from Stanford University. The authors are indebted to the California Transplant Donor Network and to the transplant programs of the California Pacific Medical Center, Stanford University Medical Center, and University of California San Francisco for making data available for this analysis. References 1. Shoskes DA, Halloran PF: Delayed graft function in renal transplantation: Etiology, management and long-term significance. J Urol 155: , Tilney NL, Guttmann RD: Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 64: , Samaniego M, Baldwin WM, Sanfilippo F: Delayed graft function: Immediate and late impact. Curr Opin Nephrol Hypertens 6: , Alejandro V, Scandling JD Jr, Sibley RK, Dafoe D, Alfrey E, Deen W, Myers BD: Mechanisms of filtration failure during postischemic injury of the human kidney: A study of the reperfused renal allograft. J Clin Invest 95: , Terasaki PI, Cecka JM, Gjertson DW, Takemoto S, Cho YW, Yuge J: Risk rate and long-term kidney transplant survival. In: Clinical Transplants, edited by Cecka JM, Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1996, pp Scornik JC, Cecka JM: Immune responsiveness and renal transplantation. In: Clinical Transplants, edited by Cecka JM, Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1996, pp Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SSY, Bear RA, Cole EH, Fenton SS, Cattran DC: Early function as the principal correlate of graft survival. Transplantation 46: 3 8, Troppmann C, Gillingham KJ, Gruessner RWG, Dunn DL, Payne WD, Najarian JS, Matas AJ: Delayed graft function in the absence of rejection has no long-term impact. Transplantation 61: , Lehtonen SR, Isoniemi HM, Salmela KT, Taskinen EI, von Willebrand EO, Ahonen JP: Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection. Transplantation 64: , Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31 41, Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34: , Moran SM, Myers BD: Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 7: , Cosio FG, Qui W, Henry ML, Falkenhain ME, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Factors related to the donor organ are major determinants of renal allograft function and survival. Transplantation 6: , Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RWG, Najarian JS, Matas A: Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 59: , Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI: Delayed graft function after renal transplantation. Transplantation 65: 19 3, Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 8: , Levy AS, Perrone RD, Madias NE: Serum creatinine and renal funciton. Annu Rev Med 39: , Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 63: , Ploeg RJ, van Bockel JH, Langendjik PTH, Groenewegen M, van der Woude FJ, Persijn GG, Thorogood J, Hermans J: Effect

7 J Am Soc Nephrol 10: , 1999 Donor Effect on Early Graft Kidney Function 133 of preservation solution on results of cadaveric kidney transplantation. Lancet 340: , Koning OH, Ploeg RJ, van Bockel JH, Groenewegen M, van der Woude FJ, Persijn GG, Hermans J: Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. Transplantation 63: , Meruisse M, Albert A, Defraigne JO, Bonnet P, Honore P, Pirenne J, Henrivaux P, Mahieu P, Beaujean MA, Limet R, Jacquet N: Multiple risk factor analysis of non-immunological delayed graft function after kidney transplantation. Clin Transplant : , Ashan N, Holman MJ, Yang HC: Kidneys transplanted from inotropic supported donors develop higher post-op ATN and poor allograft function [Abstract]. J Am Soc Nephrol 7: 1901, 1996 This article can be accessed in its entirety on the Internet at along with related UpToDate topics.

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival Nephrol Dial Transplant (2006) 21: 2270 2274 doi:10.1093/ndt/gfl103 Advance Access publication 22 May 2006 Original Article Reduced graft function (with or without dialysis) vs immediate graft function

More information

J Am Soc Nephrol 14: , 2003

J Am Soc Nephrol 14: , 2003 J Am Soc Nephrol 14: 208 213, 2003 Kidney Allograft and Patient Survival in Type I Diabetic Recipients of Cadaveric Kidney Alone Versus Simultaneous Pancreas/Kidney Transplants: A Multivariate Analysis

More information

Donor Scoring System for Cadaveric Renal Transplantation

Donor Scoring System for Cadaveric Renal Transplantation American Journal of Transplantation 2001; 1: 162 170 Copyright C Munksgaard 2001 Munksgaard International Publishers ISSN 1600-6135 Donor Scoring System for Cadaveric Renal Transplantation Scott L. Nyberg

More information

MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS

MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS, PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION, AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT

More information

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation

More information

RISK FACTORS FOR ACUTE TUBULAR NECROSIS IN 774 CADAVER RENAL TRANSPLANTATIONS

RISK FACTORS FOR ACUTE TUBULAR NECROSIS IN 774 CADAVER RENAL TRANSPLANTATIONS Clinical Urology Brazilian Journal of Urology Official Journal of the Brazilian Society of Urology Vol. 28 (2): 93-101, March - April, 2002 RISK FACTORS FOR ACUTE TUBULAR NECROSIS IN 774 CADAVER RENAL

More information

IV.13 Analysis of patient and graft survival. Guidelines. Commentary on Guidelines IV.13: Analysis of patient and graft survival

IV.13 Analysis of patient and graft survival. Guidelines. Commentary on Guidelines IV.13: Analysis of patient and graft survival 60 SECTION IV: Long-term management of the transplant recipient IV.13 Analysis of patient and graft survival Guidelines A. It is important for a transplant unit to follow-up on the results of their transplant

More information

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80% SELECTED ABSTRACTS The following are summaries of selected posters presented at the American Transplant Congress on May 5 9, 2007, in San Humar A, Gillingham KJ, Payne WD, et al. Review of >1000 kidney

More information

Morbidity and Mortality After Living Kidney Donation, : Survey of United States Transplant Centers

Morbidity and Mortality After Living Kidney Donation, : Survey of United States Transplant Centers American Journal of Transplantation 2003; 3: 830 834 Copyright # Blackwell Munksgaard 2003 Blackwell Munksgaard ISSN 1600-6135 Morbidity and Mortality After Living Kidney Donation, 1999 2001: Survey of

More information

Assessment of Deceased Donor Kidneys Using a Donor Scoring System

Assessment of Deceased Donor Kidneys Using a Donor Scoring System Original Article DOI 1.3349/ymj.1.51.6.87 pissn: 513-5796, eissn: 1976-2437 Yonsei Med J 51(6):87-876, 1 Assessment of Deceased Donor Kidneys Using a Donor Scoring System Kitae Bang, 1 Han Kyu Lee, 1 Wooseong

More information

COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS

COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS A COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS KEVIN C. MANGE, M.D.,

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 2, by the Massachusetts Medical Society VOLUME 342 M ARCH 2, 2 NUMBER 9 IMPROVED GRAFT SURVIVAL AFTER RENAL TRANSPLANTATION IN THE UNITED STATES, 1988 TO

More information

journal of medicine The new england

journal of medicine The new england The new england journal of medicine established in 1812 february 5, 2004 vol. 350 no. 6 Effect of Changing the Priority for HLA Matching on the Rates and Outcomes of Kidney Transplantation in Minority

More information

AGGRESSIVE PROMOTION of

AGGRESSIVE PROMOTION of PAPER Prolonged Cold Ischemia Time Obviates the Benefits of HLA Mismatches in Renal Transplantation Crystine M. Lee, MD; Jonathan T. Carter; Edward J. Alfrey, MD; Nancy L. Ascher, MD, PhD; John P. Roberts,

More information

Echocardiography analysis in renal transplant recipients

Echocardiography analysis in renal transplant recipients Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical

More information

Environmental Variability

Environmental Variability 1 Environmental Variability Body Size, Body Composition, Maturation and Organ Function Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 Objectives Understand the major sources

More information

Early Postoperative Urine Flow Predicts Delayed Graft Function Irrespective of Diuretic Use

Early Postoperative Urine Flow Predicts Delayed Graft Function Irrespective of Diuretic Use Early Postoperative Urine Flow Predicts Delayed Graft Function Irrespective of Diuretic Use Sunil Bhandari, PhD, FRCP * David Eisinger, MD, FRACS Josette Eris, PhD, FRACP * *Department of Transplant Medicine,

More information

Blood Pressure and the Survival of Renal Allografts from Living Donors

Blood Pressure and the Survival of Renal Allografts from Living Donors J Am Soc Nephrol 15: 187 193, 2004 Blood Pressure and the Survival of Renal Allografts from Living Donors KEVIN C. MANGE,* HAROLD I. FELDMAN,* MARSHALL M. JOFFE,* KOSUNARTY FA, and ROY D. BLOOM *Center

More information

Matching Older Kidneys with Older Patients Does Not Improve Allograft Survival

Matching Older Kidneys with Older Patients Does Not Improve Allograft Survival J Am Soc Nephrol 13: 1067 1072, 2002 Matching Older Kidneys with Older Patients Does Not Improve Allograft Survival BERTRAM L. KASISKE* and JON SNYDER* *United States Renal Data System Coordinating Center,

More information

Postoperative monitoring after

Postoperative monitoring after Postoperative monitoring after kidney transplantation Bundit sakulchairungrueng,md Vascular and Transplantation Unit Faculty of Medicine Ramathibodi Hospital Mahidol University Reference Introduction A

More information

For Immediate Release Contacts: Jenny Keeney Astellas US LLC (847)

For Immediate Release Contacts: Jenny Keeney Astellas US LLC (847) For Immediate Release Contacts: Jenny Keeney Astellas US LLC (847) 317-5405 Lauren McDonnell GolinHarris (312) 729-4233 ASTELLAS RECEIVES FDA APPROVAL FOR USE OF PROGRAF (TACROLIMUS) IN CONJUNCTION WITH

More information

The incidence of transplantation from living donors in

The incidence of transplantation from living donors in Imprecision of Creatinine-Based GFR Estimates in Uninephric Kidney Donors Jane C. Tan,* Bing Ho, Stephan Busque, Kristina Blouch,* Geraldine Derby,* Bradley Efron, and Bryan D. Myers* *Division of Nephrology,

More information

Determinants of Discard of Expanded Criteria Donor Kidneys: Impact of Biopsy and Machine Perfusion

Determinants of Discard of Expanded Criteria Donor Kidneys: Impact of Biopsy and Machine Perfusion American Journal of Transplantation 2008; 8: 783 792 Blackwell Munksgaard C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society of Transplant Surgeons

More information

Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995

Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995 Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995 Steven H. Belle, Kimberly C. Beringer, and Katherine M. Detre T he Scientific Liver Transplant Registry (LTR) was established

More information

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry American Journal of Transplantation 2016; 16: 688 693 Wiley Periodicals Inc. Brief Communication Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons doi:

More information

Review Article: In-Depth Topic. Am J Nephrol 2003;23: DOI: /

Review Article: In-Depth Topic. Am J Nephrol 2003;23: DOI: / American Journal of Nephrology Review Article: In-Depth Topic Am J Nephrol 2003;23:245 259 DOI: 10.1159/000072055 Received: May 6, 2003 Accepted: May 27, 2003 Published online: July 1, 2003 Tackling the

More information

Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients

Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients Wiley Periodicals Inc. C Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients

More information

Clinical Policy: Pancreas Transplantation Reference Number: PA.CP.MP.102

Clinical Policy: Pancreas Transplantation Reference Number: PA.CP.MP.102 Clinical Policy: Reference Number: PA.CP.MP.102 Effective Date: 01/18 Last Review Date: 03/17 Revision Log Coding Implications Description This policy describes the medical necessity requirements for pancreas

More information

The estimation of kidney function with different formulas in overall population

The estimation of kidney function with different formulas in overall population 137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil Specific management of IgA nephropathy: role of fish oil Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Early and prolonged treatment with fish oil may retard

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Assessment of donors with sub-optimal kidney function/structure GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Assessment of donors with sub-optimal kidney function/structure GUIDELINES Assessment of donors with sub-optimal kidney function/structure Date written: June 2004 Final submission: April 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR

More information

Renal Data from the Arab World

Renal Data from the Arab World Saudi J Kidney Dis Transpl 2011;22(4):818-824 2011 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from the Arab World Why does Kidney Allograft Fail?

More information

Clinical Study Over Ten-Year Kidney Graft Survival Determinants

Clinical Study Over Ten-Year Kidney Graft Survival Determinants International Nephrology Volume 2012, Article ID 302974, 5 pages doi:10.1155/2012/302974 Clinical Study Over Ten-Year Kidney Graft Survival Determinants Anabela Malho Guedes, 1, 2 Jorge Malheiro, 1 Isabel

More information

Actualités néphrologiques Jean Hamburger 23 Avril Marie Courbebaisse, Service de Physiologie Hôpital Européen Georges Pompidou, Paris

Actualités néphrologiques Jean Hamburger 23 Avril Marie Courbebaisse, Service de Physiologie Hôpital Européen Georges Pompidou, Paris Single nephron GFR Actualités néphrologiques Jean Hamburger 23 Avril 2018 Marie Courbebaisse, Service de Physiologie Hôpital Européen Georges Pompidou, Paris Introdution Glomerular filtration and SNGFR

More information

A Risk Prediction Model for Delayed Graft Function in Deceased Donor Kidney Transplantation

A Risk Prediction Model for Delayed Graft Function in Deceased Donor Kidney Transplantation Trends in Transplant. 2011;5:13-22 William D. Irish: Delayed Graft Function Risk Model A Risk Prediction Model for Delayed Graft Function in Deceased Donor Kidney Transplantation William D. Irish Health

More information

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

More information

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2. Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR

More information

RENAL TRANSPLANTATION HAS

RENAL TRANSPLANTATION HAS ORIGINAL CONTRIBUTION Arterial Hypertension and Renal Allograft Survival Kevin C. Mange, MD Borut Cizman, MD Marshall Joffe, MD, PhD Harold I. Feldman, MD, MSCE Context Several observational studies have

More information

NEPHROLOGISTS face a critical challenge

NEPHROLOGISTS face a critical challenge Meeting the Challenges of the New K/DOQI Guidelines Garabed Eknoyan, MD Substantial gains in the dialytic treatment of patients with end-stage renal disease have been made during the past several decades.

More information

Should Pediatric Patients Wait for HLA-DR-Matched Renal Transplants?

Should Pediatric Patients Wait for HLA-DR-Matched Renal Transplants? American Journal of Transplantation 2008; 8: 2056 2061 Wiley Periodicals Inc. C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society of Transplant

More information

OUT OF DATE. Choice of calcineurin inhibitors in adult renal transplantation: Effects on transplant outcomes

OUT OF DATE. Choice of calcineurin inhibitors in adult renal transplantation: Effects on transplant outcomes nep_734.fm Page 88 Friday, January 26, 2007 6:47 PM Blackwell Publishing AsiaMelbourne, AustraliaNEPNephrology1320-5358 2006 The Author; Journal compilation 2006 Asian Pacific Society of Nephrology? 200712S18897MiscellaneousCalcineurin

More information

Receiving a Kidney Transplant in the Ninth Decade of Life

Receiving a Kidney Transplant in the Ninth Decade of Life Trends Edmund in Transplant. Huang and 2011;5:121-7 Suphamai Bunnapradist: Receiving a Kidney Transplant in the Ninth Decade of Life Receiving a Kidney Transplant in the Ninth Decade of Life Edmund Huang

More information

Chapter Two Renal function measures in the adolescent NHANES population

Chapter Two Renal function measures in the adolescent NHANES population 0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you

More information

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation IJMS Vol 34, No 2, June 2009 Original Article Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation Reza Hekmat, Hamid Eshraghi Abstract Background:

More information

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health The New Kidney Allocation System: What You Need to Know Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health ~6% of patients die each year on the deceased donor waiting

More information

Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview

Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview Transplant International ISSN 0934-0874 REVIEW Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview Vincent Audard, Marie Matignon, Karine Dahan, Philippe Lang

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/29755 holds various files of this Leiden University dissertation. Author: Moes, Dirk Jan Alie Roelof Title: Optimizing immunosuppression with mtor inhibitors

More information

TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING

TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING YONG W. CHO, PH.D., PAUL I. TERASAKI, PH.D., J. MICHAEL CECKA, PH.D., AND DAVID W. GJERTSON, PH.D. ABSTRACT Background Attempts

More information

Are two better than one?

Are two better than one? Are two better than one? Disclosures Ryutaro Hirose, MD Professor in Clinical Surgery University of California, San Francisco I have no relevant disclosures related to this presentation The PROBLEM There

More information

Chapter VII. Renal Transplantation: Access and Outcomes. Methods. Key Words: Gender in transplantation

Chapter VII. Renal Transplantation: Access and Outcomes. Methods. Key Words: Gender in transplantation Annual Data Report Renal Transplantation: Access and Outcomes Chapter VII Renal Transplantation: Access and Outcomes D Key Words: Cadaveric renal transplants Living related renal transplants Transplant

More information

Hasan Fattah 3/19/2013

Hasan Fattah 3/19/2013 Hasan Fattah 3/19/2013 AASK trial Rational: HTN is a leading cause of (ESRD) in the US, with no known treatment to prevent progressive declines leading to ESRD. Objective: To compare the effects of 2 levels

More information

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients? Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration

More information

Follow-up after renal transplantation with organs from donors after cardiac death

Follow-up after renal transplantation with organs from donors after cardiac death Transplant International ISSN 0934-0874 ORIGINAL ARTICLE Follow-up after renal transplantation with organs from donors after cardiac death Jeremy Chapman, 1 Andreas Bock, 2 Bertrand Dussol, 3 Lutz Fritsche,

More information

Scores in kidney transplantation: How can we use them?

Scores in kidney transplantation: How can we use them? Scores in kidney transplantation: How can we use them? Actualités Néphrologiques 2017 M Hazzan (Lille France ) Contents Scores to estimate the quality of the graft Scores to estimate old candidates to

More information

Older Living Kidney Donors and Recipients. Charles Le University of Colorado 6/24/11

Older Living Kidney Donors and Recipients. Charles Le University of Colorado 6/24/11 Older Living Kidney Donors and Recipients Charles Le University of Colorado 6/24/11 Clinical Scenario HPI: 60 y/o healthy AAM with h/o CKD5 on HD x 2 yrs 2/2 HTN, was evaluated in transplant clinic for

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Randall C Starling MD MPH FACC FAHA FESC FHFSA Professor of Medicine Kaufman Center for Heart Failure Department of Cardiovascular

More information

Lecture-2 Review of the previous lecture:

Lecture-2 Review of the previous lecture: Lecture-2 Review of the previous lecture: -Kidney s function is to clean the blood by the removing of the waste plus adding some valuable substances -kidney failure will lead to death for many reasons,

More information

En-Bloc Kidney Transplantation in the United States: An Analysis of United Network of Organ Sharing (UNOS) Data from 1987 to 2003

En-Bloc Kidney Transplantation in the United States: An Analysis of United Network of Organ Sharing (UNOS) Data from 1987 to 2003 American Journal of Transplantation 2005; 5: 1513 1517 Blackwell Munksgaard Copyright C Blackwell Munksgaard 2005 doi: 10.1111/j.1600-6143.2005.00878.x En-Bloc Kidney Transplantation in the United States:

More information

Our Experiences in Kidney Transplantation and Monitoring of Kidney Graft Outcomes

Our Experiences in Kidney Transplantation and Monitoring of Kidney Graft Outcomes & Our Experiences in Kidney Transplantation and Monitoring of Kidney Graft Outcomes Rašić Senija¹*, Džemidžić Jasminka¹, Aganović Kenana¹, Aganović Damir², Prcić Alden² 1. Institute of Nephrology, Clinical

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

The New England Journal of Medicine KIDNEY TRANSPLANTATION FROM DONORS WITHOUT A HEARTBEAT

The New England Journal of Medicine KIDNEY TRANSPLANTATION FROM DONORS WITHOUT A HEARTBEAT KIDNEY TRANSPLANTATION FROM DONORS WITHOUT A HEARTBEAT MARKUS WEBER, M.D., DANIEL DINDO, M.D., NICHOLAS DEMARTINES, M.D., PATRICE M. AMBÜHL, M.D., AND PIERRE-ALAIN CLAVIEN, PH.D. ABSTRACT Background The

More information

Pancreas after Kidney Transplants in Posturemic Patients with Type I Diabetes Mellitus

Pancreas after Kidney Transplants in Posturemic Patients with Type I Diabetes Mellitus J Am Soc Nephrol 12: 2490 2499, 2001 Pancreas after Kidney Transplants in Posturemic Patients with Type I Diabetes Mellitus ANGELIKA C. GRUESSNER, DAVID E. R. SUTHERLAND, DAVID L. DUNN, JOHN S. NAJARIAN,

More information

Renal Transplantation in the First Year of Life: The Treatment of Choice for Infants With End-Stage Renal Disease

Renal Transplantation in the First Year of Life: The Treatment of Choice for Infants With End-Stage Renal Disease Renal Transplantation in the First Year of Life: The Treatment of Choice for Infants With End-Stage Renal Disease John S. Najarian,1 P. Stephen Almond, Michael Mauer, Blanche Chavers, Thomas Nevins, Clifford

More information

KEEP 2.0 Annual Data Report Chapter Five

KEEP 2.0 Annual Data Report Chapter Five KEEP 2. Annual Data Report Chapter Five Figure 5.1 percent distribution of KEEP participants with elevated serum creatinine levels, overall & by age 16 Percent of participants 12 8 4 All

More information

Effect of donor age on the outcome of living-related kidney transplantation

Effect of donor age on the outcome of living-related kidney transplantation Transplant International ISSN 0934-0874 ORIGINAL ARTICLE Effect of donor age on the outcome of living-related kidney transplantation Radomir Naumovic, 1 Ljubica Djukanovic, 1 Jelena Marinkovic 2 and Visnja

More information

Special Challenges and Co-Morbidities

Special Challenges and Co-Morbidities Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine

More information

Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19)

Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19) Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19) Data Collection Method: This measure is calculated based on data extracted from the electronic medical record combined with administrative data

More information

NIH Public Access Author Manuscript Transplant Proc. Author manuscript; available in PMC 2010 July 14.

NIH Public Access Author Manuscript Transplant Proc. Author manuscript; available in PMC 2010 July 14. NIH Public Access Author Manuscript Published in final edited form as: Transplant Proc. 1990 February ; 22(1): 17 20. The Effects of FK 506 on Renal Function After Liver Transplantation J. McCauley, J.

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors Cardiovascular Risk Factors ROB WALKER (Dunedin, New Zealand) Lipid-lowering therapy in patients with chronic kidney disease Date written: January 2005 Final submission: August 2005 Author: Rob Walker

More information

Treated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996

Treated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996 Annual Data Report International Comparisons of ESRD Therapy Chapter XI International Comparisons of ESRD Therapy O ver the last decade a growing number of national and regional registries dealing with

More information

Donor Quality Assessment

Donor Quality Assessment Donor Quality Assessment Francesc Moreso, MD, PhD Renal Transplant Unit Hospital Universitari Vall d Hebron Barcelona. Spain 4/9/2017 Donor Quality Assessment 1 What is the problem? Across all age ranges,

More information

HLA-Matched Kidney Transplantation in the Era of Modern Immunosuppressive Therapy

HLA-Matched Kidney Transplantation in the Era of Modern Immunosuppressive Therapy HLA-Matched Kidney Transplantation in the Era of Modern Immunosuppressive Therapy Arun Amatya, MD; Sandy Florman, MD; Anil Paramesh, MD; Anup Amatya, PhD Jennifer McGee, MD; Mary Killackey, MD; Quing Ren,

More information

Kidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania

Kidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Kidney Transplant Outcomes In Elderly Patients Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Case Discussion 70 year old Asian male, neuropsychiatrist, works full

More information

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital Transplant Options for Patients: Choices and Consequences Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital BC Kidney Days October 6 th 2017 Non contributory Conflict of

More information

Current status of kidney and pancreas transplantation in the United States,

Current status of kidney and pancreas transplantation in the United States, American Journal of Transplantation 25; 5 (Part 2): 94 915 Blackwell Munksgaard Blackwell Munksgaard 25 Current status of kidney and pancreas transplantation in the United States, 1994 23 Gabriel M. Danovitch

More information

Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys?

Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys? Nephrol Dial Transplant (2017) 32: 1934 1938 doi: 10.1093/ndt/gfx257 Advance Access publication 21 August 2017 Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality

More information

Overview. Evaluation of Potential Kidney Transplant Recipients. Projected Years of Life in Patients with ESRD

Overview. Evaluation of Potential Kidney Transplant Recipients. Projected Years of Life in Patients with ESRD Evaluation of Potential Kidney Transplant Recipients Donald E. Hricik MD Professor of Medicine and Chief, Division of Nephrology and Hypertension University Hospitals Case Medical Center Conflict of Interest

More information

Kidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P.

Kidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P. Kidney Transplant in the Elderly! Robert Santella, M.D., F.A.C.P. Incident Rate of ESRD by Age Age 75+ 65-74 From US Renal Data System, 2012 Should there be an age limit? Various guidelines: Canadian,

More information

James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant

James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant Program Has no real or apparent conflicts of interest

More information

Dialysis Adequacy (HD) Guidelines

Dialysis Adequacy (HD) Guidelines Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of

More information

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review Jessica Ludolph 1 Lynsey Biondi, MD 1,2 and Michael Moritz, MD 1,2 1 Department of Surgery,

More information

OUT OF DATE. Donor renal function. Date written: August 2009nep_1223 Final submission: June 2009 Author: Solomon Cohney, John Kanellis, Martin Howell

OUT OF DATE. Donor renal function. Date written: August 2009nep_1223 Final submission: June 2009 Author: Solomon Cohney, John Kanellis, Martin Howell 137..145 NEPHROLOGY 2010; 15, S137 S145 doi:10.1111/j.1440-1797.2009.01223.x Date written: August 2009nep_1223 Final submission: June 2009 Author: Solomon Cohney, John Kanellis, Martin Howell Donor renal

More information

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures The new kidney allocation system (KAS) what has it done? Disclosures No financial disclosure Ryutaro Hirose, MD Professor in Clinical Surgery University of California San Francisco Objectives Describe

More information

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Kidney Transplantation in the Elderly Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Agenda Background: Age and chronic kidney disease End stage kidney disease:

More information

"SUBOPTIMAL" KIDNEY DONORS

SUBOPTIMAL KIDNEY DONORS 0041-1337196169-1242$03.0010 TRANSPLANTATION Copyright 1996 by Williams &: Wilkins /177 VoL "SUBOPTIMAL" KIDNEY DONORS THE EXPERIENCE WITH TACROLIMUS-BASED IMMUNOSUPPRESSION 62, 1242-1246, No.9, November

More information

Intruduction PSI MODE OF ACTION AND PHARMACOKINETICS

Intruduction PSI MODE OF ACTION AND PHARMACOKINETICS Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation Andreas Zuckermann, MD et al. Department of Cardio-Thoracic Surgery, Medical University

More information

Salt Sensitivity in Blacks

Salt Sensitivity in Blacks ONLINE SUPPLEMENT Salt Sensitivity in Blacks Evidence That the Initial Pressor Effect of NaCl Involves Inhibition of Vasodilatation by Asymmetrical Dimethylarginine Olga Schmidlin 1, Alex Forman 1, Anna

More information

The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function

The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function American Journal of Transplantation 2008; 8: 78 85 Blackwell Munksgaard C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society of Transplant Surgeons

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.

More information

CHAPTER 14. Renal Transplantation

CHAPTER 14. Renal Transplantation 15th Report of the Malaysian RENAL TRANSPLANTATION CHAPTER 14 Renal Transplantation Editor: Dr. Goh Bak Leong Expert Panel: : Dato Dr. Dato Zaki Dr. Morad Zaik Morad Mohd (Chair) Zaher (Chair) Dr. Goh

More information

Renal allograft loss in the first post-operative month: causes and consequences

Renal allograft loss in the first post-operative month: causes and consequences Clin Transplant 2012 DOI: 10.1111/j.1399-0012.2011.01581.x ª 2012 John Wiley & Sons A/S. Renal allograft loss in the first post-operative month: causes and consequences Phelan PJ, OÕKelly P, Tarazi M,

More information

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of

More information

Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs

Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs LIVER TRANSPLANTATION 14:303-307, 2008 ORIGINAL ARTICLE Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs Kevin P. Charpentier 1 and Arun Mavanur 2 1 Rhode

More information

Transplantation/Vascular Surgery. The Socioeconomic Status of Donors and Recipients of Living Unrelated Renal Transplants in the United States

Transplantation/Vascular Surgery. The Socioeconomic Status of Donors and Recipients of Living Unrelated Renal Transplants in the United States Transplantation/Vascular Surgery The Socioeconomic Status of Donors and Recipients of Living Unrelated Renal Transplants in the United States John L. Gore,* Jennifer S. Singer, Arleen F. Brown and Gabriel

More information